tetraisopropylpyrophosphamide has been researched along with Acute Disease in 1 studies
Tetraisopropylpyrophosphamide: N,N',N'',N'''-Tetraisopropylpyrophosphamide. A specific inhibitor of pseudocholinesterases. It is commonly used experimentally to determine whether pseudo- or acetylcholinesterases are involved in an enzymatic process.
Acute Disease: Disease having a short and relatively severe course.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, S | 1 |
| Oguchi, Y | 1 |
| Borner, JW | 1 |
| Runge, W | 1 |
| Dressel, TD | 1 |
| Goodale, RL | 1 |
1 other study available for tetraisopropylpyrophosphamide and Acute Disease
| Article | Year |
|---|---|
Increased canine pancreatic acinar cell damage after organophosphate and acetylcholine or cholecystokinin.
Topics: Acetylcholine; Acute Disease; Animals; Cholecystokinin; Dogs; Drug Synergism; Echothiophate Iodide; | 1990 |